Patents by Inventor Satya Krishna Kishore Ravuri

Satya Krishna Kishore Ravuri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC PROTEINS AND METHODS OF USE
    Publication number: 20230406930
    Abstract: The disclosure provides pharmaceutical compositions of therapeutic proteins and methods of using the same.
    Type: Application
    Filed: April 13, 2023
    Publication date: December 21, 2023
    Inventors: Junyan JI, Ellen Dorothee MEUX, Satya Krishna Kishore RAVURI, Karin SCHOENHAMMER, Jacqueline Yvonne TYLER, Ilona Elisabeth VOLLRATH, Adithi Chandrasekhara BHARGAVA, Jeremy Jean-Pierre DUBOEUF
  • PHARMACEUTICAL COMPOSITIONS OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND METHODS OF USE
    Publication number: 20230348628
    Abstract: The present invention relates to pharmaceutical compositions of anti-CD20/anti-CD3 bispecific antibodies and methods of using the same.
    Type: Application
    Filed: April 13, 2023
    Publication date: November 2, 2023
    Inventors: Ellen Dorothee MEUX, Satya Krishna Kishore RAVURI, Karin SCHOENHAMMER, Ilona Elisabeth VOLLRATH, Jérémy Jean-Pierre DUBOEUF
  • USE OF CHELATORS FOR THE PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN SOLUTIONS
    Publication number: 20230233684
    Abstract: The present invention provides methods to prevent the formation of visible particles in aqueous protein formulations, in particular the use of certain chelators, as well as compositions and pharmaceutical products obtained with said method.
    Type: Application
    Filed: November 9, 2022
    Publication date: July 27, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Kathrin GREGORITZA, Andrea ALLMENDINGER, Satya Krishna Kishore RAVURI
  • PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN SOLUTIONS
    Publication number: 20230167172
    Abstract: The present invention provides methods to prevent the formation of visible particles in aqueous protein formulations, as well as compositions and pharmaceutical products obtained with said method.
    Type: Application
    Filed: November 10, 2022
    Publication date: June 1, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Keijiro HATADE, Stefan Josef FISCHER, Christina Roswitha HAEUSER, Stephen Alfred HYLAND, Tarik Ali KHAN, Ralph LOVIS, Satya Krishna Kishore RAVURI, Hitoshi SASAKI
  • CSF-1R ANTIBODY FORMULATION
    Publication number: 20210205453
    Abstract: The present invention relates to a stable liquid pharmaceutical formulation comprising 40 mg/ml to 200 mg/ml of an antibody against CSF-1R; 0.01% (w/v) to 0.1% (w/v) of surfactant; 5 mM to 100 mM of a buffer agent; and 10 mM to 500 mM of at least one stabilizer; at a pH in the range from 4.5 to 7.0.
    Type: Application
    Filed: March 11, 2021
    Publication date: July 8, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Satya Krishna Kishore RAVURI, Kewei YANG
  • Methods for purification of polypeptides using polysorbates
    Publication number: 20210155656
    Abstract: Herein is reported a method for purifying a protein from a sample comprising the protein and at least one impurity with hydrolytic activity, comprising the following steps: i) a) applying the sample comprising the protein and at least one impurity with hydrolytic activity to a chromatography material, b) applying a solution which comprises a polysorbate to the chromatography material, and c) recovering the protein from the chromatography material, or ii) a) adding a polysorbate to the sample comprising the protein and at least one impurity with hydrolytic activity, b) applying the mixture of step a) to a chromatography material, and c) recovering the protein from the chromatography material, or iii) a) adding a polysorbate to the sample comprising the protein and at least one impurity with hydrolytic activity, b) applying the mixture of step a) to a chromatography material, c) applying a solution which comprises a polysorbate to the chromatography material, and d) recovering the protein from the chr
    Type: Application
    Filed: October 26, 2020
    Publication date: May 27, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Roberto FALKENSTEIN, Michael LEISS, Bernhard SPENSBERGER, Satya Krishna Kishore RAVURI
  • PHARMACEUTICAL FORMULATION FOR PROTEINS
    Publication number: 20120294866
    Abstract: The present invention provides a liquid pharmaceutical formulation comprising a therapeutic protein, a surfactant and at least an antioxidant selected from the group of radical scavengers, chelating agents or chain terminators.
    Type: Application
    Filed: January 14, 2010
    Publication date: November 22, 2012
    Applicant: F. HOFFMANN-LA ROCHE AG
    Inventors: Hanns-Christian Mahler, Satya Krishna Kishore Ravuri